Dr. Sonpavde on Trials of Immunotherapy in Bladder Cancer – OncLive
OncLive |
Dr. Sonpavde on Trials of Immunotherapy in Bladder Cancer
OncLive Guru Sonpavde, MD, director of Bladder Cancer at Dana-Farber Cancer Institute, discusses current trials of immunotherapy in bladder cancer. The second-line therapy of bladder cancer has been revolutionized by the approvals of multiple PD-1/PD-L1 … |
